| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.2 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |